Dr. Karen Jacobson joined the Vaccine Study Center at the Kaiser Permanente Northern California Division of Research in 2023 as a Research Scientist. She is a board-certified Infectious Diseases physician.
Dr. Jacobson obtained a bachelor of arts in Human Biology from Stanford University and a doctor of medicine and master of Public Health from the Icahn School of Medicine at Mount Sinai. She completed her residency training in Internal Medicine/HIV Primary Care at the Yale-New Haven Hospital and her fellowship in Infectious Diseases at Stanford.
Dr. Jacobson’s research is focused on mitigating sequelae of infectious diseases, particularly SARS-CoV-2. She is co-Investigator of multiple outpatient studies of treatments for acute and convalescent SARS-CoV-2 disease, and her published work has described clinical and immunologic correlations of Long COVID and risk of post-vaccination infection with SARS-CoV-2 variants of concern. Dr. Jacobson is the recipient of the Burroughs Wellcome-ASTMH Fellowship in Tropical Infectious Diseases, a Thrasher Fund Early Career Award, and a National Institute of Allergy and Infectious Diseases (NIAID)-funded Mentored Patient-Oriented Research Career Development Award (K23AI177817) evaluating sequelae of maternal SARS-CoV-2 infection and vaccination on early infant outcomes in Uganda.
Current Positions
- Research Scientist
Section Affiliations
Primary Research Interests
- Mitigating sequelae of infectious diseases
- SARS-CoV-2 disease
